Metabolic Medicine · Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency

Long-Term Complications & Monitoring

At a Glance

Long-term complications of LCHAD deficiency can include pigmentary retinopathy, peripheral neuropathy, and cardiomyopathy. Even with strict dietary management, children require routine, lifelong monitoring by a multidisciplinary medical team to catch and treat these issues early.

While the immediate focus of LCHAD deficiency is often on preventing a metabolic crisis, long-term care involves monitoring for specific complications that can develop over time. It is important to understand that some of these issues may progress even with excellent dietary management ^[1]. However, regular screening allows your care team to intervene early and adjust treatments to provide your child with the best possible quality of life ^[2].

The Eyes: Pigmentary Retinopathy

The most specific long-term complication of LCHAD deficiency is pigmentary retinopathy (also called chorioretinopathy). This is a progressive condition that affects the retina, the light-sensing part of the eye ^[1].

Why it happens: Experts believe the same toxic long-chain fats that cause metabolic crises also damage the delicate cells of the retina over time ^[3]^[4].
What to expect: It often begins as a “rod-cone dystrophy,” which can lead to night blindness or a loss of peripheral vision ^[4].
The Diet’s Role: Early diagnosis and a strict diet help, but they do not always stop the progression of eye changes ^[5].

Important Note: Recent research suggests that the retinal cells in LCHAD deficiency are very sensitive to oxidative stress. Some studies have even raised questions about the safety of DHA (omega-3) supplements, suggesting they might actually increase stress on these specific eye cells ^[6]. Explicitly ask your metabolic specialist and ophthalmologist about their current stance on DHA supplementation at your next visit.

The Nerves: Peripheral Neuropathy

As children with LCHAD deficiency grow into adolescence, they may develop peripheral neuropathy ^[7]. This is damage to the nerves that carry messages between the brain and the rest of the body.

Symptoms: You might notice your child being “clumsy,” tripping more often, or complaining of numbness, tingling, or “pins and needles” in their hands and feet ^[8].
Monitoring: Specialists can use imaging (like MRN) or physical exams to check for nerve health. In some cases, this neuropathy can look similar to other genetic nerve conditions, so specialized testing is key ^[7]^[8].

The Heart: Cardiomyopathy

The heart is a muscle that works 24/7 and needs a constant supply of energy. In LCHAD deficiency, the heart can become weakened if it cannot get enough fuel or if toxic fats build up in the heart tissue ^[9].

Risk: This is most common during a metabolic crisis but can also develop slowly over time.
Prevention: Keeping metabolic crises at bay is the best way to protect the heart ^[10]. Regular echocardiograms (ultrasounds of the heart) are used to ensure the heart muscle remains strong and healthy ^[11].

Your Long-Term Surveillance Guide

Because LCHAD affects multiple systems, your child will need a “team” of specialists. While schedules vary, the following is a common long-term monitoring plan ^[12]^[13]:

Specialist	Focus Area	Common Frequency
Metabolic Specialist	Overall management, routine liver function and muscle enzyme (CK) checks	Every 3–6 months
Metabolic Dietitian	Growth and dietary adjustments	Every 3–6 months
Ophthalmologist	Retinal health and vision testing	At least annually
Cardiologist	Heart function (Echocardiogram/EKG)	At least annually
Neurologist	Nerve health and motor skills	As needed or annually

Maintaining this schedule is vital. Even if your child feels perfectly healthy, these regular check-ups can catch subtle changes in the eyes, heart, or nerves before they become serious problems ^[2]^[14].

Common questions in this guide

What are the long-term eye complications of LCHAD deficiency?

Children with LCHAD deficiency can develop pigmentary retinopathy, a progressive condition affecting the light-sensing part of the eye. This often begins as night blindness or a loss of peripheral vision and requires regular evaluation by an ophthalmologist.

Can a strict diet completely prevent LCHAD deficiency complications?

While strict dietary management and early diagnosis are critical, they do not always prevent the progression of certain long-term complications, particularly vision changes. Routine screening is necessary to catch and manage any developing issues early.

Is it safe for my child with LCHAD deficiency to take DHA supplements?

Recent research indicates that retinal cells in LCHAD deficiency are highly sensitive to oxidative stress, which has raised concerns about the safety of DHA omega-3 supplements. You should discuss the most current recommendations for DHA with your child's metabolic specialist and ophthalmologist.

What are the signs of peripheral neuropathy in LCHAD deficiency?

As children with LCHAD deficiency grow, they may develop nerve damage called peripheral neuropathy. Signs include increased clumsiness, frequent tripping, or complaints of numbness, tingling, and pins and needles in their hands and feet.

How does LCHAD deficiency affect the heart over time?

The heart requires a constant supply of energy and can become weakened, leading to cardiomyopathy, if toxic fats build up or fuel is low. Keeping metabolic crises at bay and performing regular echocardiograms are the best ways to protect and monitor heart health.

Curated prompts to bring to your next appointment.

1.What is our specific schedule for ophthalmology exams, and what tests (like ERG or OCT) will they perform to monitor the retina?
2.How often should my child have an echocardiogram to check their heart function?
3.Are there specific physical or occupational therapy assessments we should do to check for early signs of peripheral neuropathy?
4.Based on recent research about DHA and oxidative stress in LCHAD-deficient eyes, what is your current stance on DHA supplementation for my child?
5.How often do we need to check long-chain acylcarnitine levels to see if our current dietary management is working?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (14)

1
Ophthalmic Symptoms of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: A Report of Three Cases.
Lange N, Bodetko AM, Mozrzymas R, Kowal-Lange A
Case reports in ophthalmology 2024; (15(1)):310-319 doi:10.1159/000537895.
PMID: 38595698
2
[Newborn screening in France: news and perspectives].
Gernez E, Roland E, Dhaenens CM, et al.
Annales de biologie clinique 2024; (82(1)):24-31 doi:10.1684/abc.2024.1869.
PMID: 38638016
3
Role of 3-Hydroxy Fatty Acid-Induced Hepatic Lipotoxicity in Acute Fatty Liver of Pregnancy.
Natarajan SK, Ibdah JA
International journal of molecular sciences 2018; (19(1)) doi:10.3390/ijms19010322.
PMID: 29361796
4
A proposal for an updated staging system for LCHADD retinopathy.
Wongchaisuwat N, Gillingham MB, Yang P, et al.
Ophthalmic genetics 2024; (45(2)):140-146 doi:10.1080/13816810.2024.2303682.
PMID: 38288966
5
A Focus on the Role of Dietary Treatment in the Prevention of Retinal Dysfunction in Patients with Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: A Systematic Review.
Maines E, Gugelmo G, Vitturi N, et al.
Children (Basel, Switzerland) 2025; (12(3)) doi:10.3390/children12030374.
PMID: 40150656
6
iPSC-Derived LCHADD Retinal Pigment Epithelial Cells Are Susceptible to Lipid Peroxidation and Rescued by Transfection of a Wildtype AAV-HADHA Vector.
DeVine T, Elizondo G, Gaston G, et al.
Investigative ophthalmology & visual science 2024; (65(11)):22 doi:10.1167/iovs.65.11.22.
PMID: 39283617
7
MR Neurography in Children and Adolescents: Multiparametric Assessment of Peripheral Nerve Involvement in Long-chain Fatty Acid Oxidation Disorders.
Preisner F, Garbade SF, Grünert SC, et al.
Investigative radiology 2026; doi:10.1097/RLI.0000000000001274.
PMID: 41626767
8
Mitochondrial trifunctional protein deficiency: an adult patient with similar progress to Charcot-Marie-Tooth disease.
Yamamoto Y, Matsui N, Hiramatsu Y, et al.
Rinsho shinkeigaku = Clinical neurology 2017; (57(2)):82-87 doi:10.5692/clinicalneurol.cn-000976.
PMID: 28132977
9
Deregulation of mitochondrial functions provoked by long-chain fatty acid accumulating in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial permeability transition deficiencies in rat heart--mitochondrial permeability transition pore opening as a potential contributing pathomechanism of cardiac alterations in these disorders.
Cecatto C, Hickmann FH, Rodrigues MD, et al.
The FEBS journal 2015; (282(24)):4714-26 doi:10.1111/febs.13526.
PMID: 26408230
10
Tutorial: Triheptanoin and Nutrition Management for Treatment of Long-Chain Fatty Acid Oxidation Disorders.
Norris MK, Scott AI, Sullivan S, et al.
JPEN. Journal of parenteral and enteral nutrition 2021; (45(2)):230-238 doi:10.1002/jpen.2034.
PMID: 33085788
11
Response to triheptanoin therapy in critically ill patients with LC-FAOD: Report of patients treated through an expanded access program.
Vockley J, Enns GM, Ramirez AN, et al.
Molecular genetics and metabolism 2022; (136(2)):152-162 doi:10.1016/j.ymgme.2022.04.001.
PMID: 35459555
12
Long-term monitoring of fatty acid oxidation defects: results from a MetabERN survey.
Schwantje M, Grünert SC, Fuchs SA
Orphanet journal of rare diseases 2024; (19(1)):21 doi:10.1186/s13023-024-03024-0.
PMID: 38245779
13
A novel HADHA variant associated with an atypical moderate and late-onset LCHAD deficiency.
Dessein AF, Hebbar E, Vamecq J, et al.
Molecular genetics and metabolism reports 2022; (31()):100860 doi:10.1016/j.ymgmr.2022.100860.
PMID: 35782617
14
Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and progressive retinopathy: one case report followed by ERGs, VEPs, EOG over a 17-year period.
Rigaudière F, Delouvrier E, Le Gargasson JF, et al.
Documenta ophthalmologica. Advances in ophthalmology 2021; (142(3)):371-380 doi:10.1007/s10633-020-09802-y.
PMID: 33392894

This page is for informational purposes only and does not replace professional medical advice. Always consult your child's metabolic specialist and healthcare team before altering their diet or supplement routine.

Get notified when new evidence is published on Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents